HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shilan Mozaffari Selected Research

Carnitine (L-Carnitine)

8/2014Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shilan Mozaffari Research Topics

Disease

6Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
04/2024 - 01/2010
4Diarrhea
02/2024 - 04/2013
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2015 - 03/2009
3Constipation
05/2014 - 04/2013
2Inflammation (Inflammations)
02/2024 - 12/2011
2Opioid-Induced Constipation
07/2018 - 01/2018
2Pain (Aches)
01/2018 - 04/2013
2Crohn Disease (Crohn's Disease)
07/2017 - 05/2014
2Abdominal Pain (Pain, Abdominal)
03/2015 - 01/2010
1Chronic Disease (Chronic Diseases)
07/2023
1Chronic Pain
07/2018
1Neoplasms (Cancer)
01/2018
1Fistula
07/2017
1Flatulence
03/2015
1Colitis
08/2014
1Ulcerative Colitis
05/2014
1Progressive Multifocal Leukoencephalopathy
05/2014
1Hypersensitivity (Allergy)
04/2013

Drug/Important Bio-Agent (IBA)

3MelatoninIBA
04/2013 - 01/2010
2Opioid Analgesics (Opioids)IBA
07/2018 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017 - 07/2011
2renzaprideIBA
05/2014 - 02/2014
2ramosetron (Nasea)IBA
05/2014 - 04/2013
2AntioxidantsIBA
12/2012 - 12/2011
1Opioid Receptors (Opioid Receptor)IBA
02/2024
1Investigational DrugsIBA
02/2024
1TachykininsIBA
02/2024
1CannabinoidsIBA
02/2024
1methylnaltrexoneFDA Link
07/2018
1Narcotic Antagonists (Opioid Antagonists)IBA
01/2018
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2018
1Certolizumab PegolFDA Link
07/2017
1Adalimumab (Humira)FDA Link
07/2017
1AntibodiesIBA
07/2017
1Thiobarbituric Acid Reactive SubstancesIBA
08/2014
1Butyrates (Butyrate)IBA
08/2014
1Carnitine (L-Carnitine)FDA LinkGeneric
08/2014
1Natalizumab (Tysabri)FDA Link
05/2014
1linaclotideIBA
05/2014
1Serotonin (5 Hydroxytryptamine)IBA
02/2014
1Glucagon-Like Peptides (Enteroglucagon)IBA
04/2013
1Pregabalin (Lyrica)FDA Link
04/2013
1mosaprideIBA
04/2013
1pexacerfontIBA
04/2013
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
04/2013
1prucaloprideIBA
04/2013
1CRF receptor type 1IBA
04/2013
1asimadolineIBA
04/2013
1Gabapentin (Neurontin)FDA LinkGeneric
04/2013
1Parasympatholytics (Antispasmodics)IBA
12/2012
1Free RadicalsIBA
12/2011
1CytokinesIBA
07/2011
1Lipid PeroxidesIBA
07/2011
1Peroxidase (Myeloperoxidase)IBA
07/2011
1Plant ExtractsIBA
03/2009

Therapy/Procedure

9Therapeutics
04/2024 - 03/2009
1Polypharmacy
07/2023
1Pain Management
07/2018
1Palliative Care (Palliative Therapy)
07/2018
1Analgesia
01/2018